within Pharmacolibrary.Drugs.ATC.J;

model J07CA05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0.5 / 1000000,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>The diphtheria-hepatitis B-pertussis-tetanus vaccine is a combination vaccine used for immunization against diphtheria, hepatitis B, pertussis (whooping cough), and tetanus. It is commonly used in pediatric vaccination schedules to provide protection against all four diseases. This vaccine is widely approved and used globally.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are not typically measured or relevant for vaccines, including this combination vaccine, as they do not act through systemic distribution but rather initiate an immune response. No published studies reporting classical pharmacokinetic parameters (compartmental distribution, clearance, etc.) for this vaccine were identified.</p><h4>References</h4><ol><li><p>Lugo, RA, &amp; Kern, SE (2002). Clinical pharmacokinetics of morphine. <i>Journal of pain &amp; palliative care pharmacotherapy</i> 16(4) 5–18. DOI:<a href=&quot;https://doi.org/10.1080/j354v16n04_02&quot;>10.1080/j354v16n04_02</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/14635822/&quot;>https://pubmed.ncbi.nlm.nih.gov/14635822</a></p></li><li><p>Wang, W, et al., &amp; Balthasar, JP (2008). Monoclonal antibody pharmacokinetics and pharmacodynamics. <i>Clinical pharmacology and therapeutics</i> 84(5) 548–558. DOI:<a href=&quot;https://doi.org/10.1038/clpt.2008.170&quot;>10.1038/clpt.2008.170</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18784655/&quot;>https://pubmed.ncbi.nlm.nih.gov/18784655</a></p></li><li><p>Groborz, O, et al., &amp; Hrubý, M (2022). Pharmacokinetics of Intramuscularly Administered Thermoresponsive Polymers. <i>Advanced healthcare materials</i> 11(22) e2201344–None. DOI:<a href=&quot;https://doi.org/10.1002/adhm.202201344&quot;>10.1002/adhm.202201344</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36153823/&quot;>https://pubmed.ncbi.nlm.nih.gov/36153823</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J07CA05;
